Literature DB >> 4033925

Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.

S T DeKosky, S W Scheff, W R Markesbery.   

Abstract

Cholinergic enzyme activity (choline acetyltransferase, CAT; acetylcholinesterase, AChE) and muscarinic cholinergic receptor density were measured in frontal cortex (Brodmann's area 9) of normal patients over the life span and in brains of patients with Alzheimer's disease (AD). CAT, but not AChE activity, declined with normal aging. Significant loss of CAT and AChE activity occurred in the AD brains, but later onset AD was associated with less severe loss of frontal cortex CAT activity. The majority of normal CAT activity resided in lamina I, II, and upper lamina III; CAT loss in AD resulted in large losses from all depths, most notably the upper cortical layers. AChE did not precisely correspond to the localization of CAT; loss of AChE in AD was consistent across all six laminae. No differences were seen in muscarinic cholinergic receptor binding between AD and age-matched controls; the distribution of binding was equal in all layers of normal frontal cortex, and no laminar differences were detected in distribution of cholinergic receptors between normal and AD samples.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033925     DOI: 10.1212/wnl.35.10.1425

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Reactive synaptogenesis in aging and Alzheimer's disease: lessons learned in the Cotman laboratory.

Authors:  Stephen Scheff
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

2.  Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.

Authors:  M D Ikonomovic; W E Klunk; E E Abrahamson; J Wuu; C A Mathis; S W Scheff; E J Mufson; S T DeKosky
Journal:  Neurology       Date:  2011-06-22       Impact factor: 9.910

3.  Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy.

Authors:  S J Kish; L Schut; J Simmons; J Gilbert; L J Chang; M Rebbetoy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

4.  Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Jessica A Ash; Brian E Powers; Ramon Velazquez; Melissa J Alldred; Milos D Ikonomovic; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

5.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.

Authors:  T P Wong; T Debeir; K Duff; A C Cuello
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

7.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

8.  Functional and neurobiological similarities of aging in monkeys and humans.

Authors:  M L Voytko
Journal:  Age (Omaha)       Date:  1997-01

Review 9.  Advances in understanding the mechanisms and management of persistent pain in older adults.

Authors:  J F Karp; J W Shega; N E Morone; D K Weiner
Journal:  Br J Anaesth       Date:  2008-05-16       Impact factor: 9.166

10.  Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Authors:  Sylvia E Perez; Saleem Dar; Milos D Ikonomovic; Steven T DeKosky; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2007-06-27       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.